Is a complete AIM/IMM research report available?

No complete published report is available for aim/IMM (AIM/IMM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AIM/IMM (AIM/IMM)

London Stock Exchange AIM: AIM/IMM · GBX

GBX 4.50

+0.50 (+12.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AIM/IMM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	28.1M
Net income (ttm)	-1.8M
EPS (ttm)	-GBX 0.00
Shares out	623.9M
Volume	660,705
Beta	3.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.8M
EPS (ttm): -GBX 0.00
Market cap: 28.1M

All AIM/IMM indicators

Market & fundamental data

Available fields

162

Groups with data

Currency

GBP

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	7
Employees Change	1%
Employees Change Percent	16.67
Enterprise value	GBX 26.7M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB0033711010
Last refreshed	2026-07-27
Market cap	GBX 28.1M
Price	GBX 4.5
Price currency	GBX
Sector	Healthcare
Sector PE	20.57
Sector PE Fwd	14.48
Sic	2836
Symbol	aim/IMM
Website	https://www.immupharma.co.uk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.44%
FCF yield	-8.46%
P/B ratio	40.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	GBX -1.8M
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Profit Per Employee	GBX -258,237
Profitable Quarters	GBX 1
ROA	-110.9
Roa5y	-64.19
ROCE	-368.9
ROE	-2,510.6
Roe5y	-773.4
ROIC	-2,199.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-19.32%
Cagr15y	-17.1%
Cagr1y	112.88%
Cagr20y	-12.36%
Cagr3y	21.56%
Cagr5y	-12.39%
EPS Growth Quarters	1
EPS Growth Years	7
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 1.9M
Cash	GBX 1.4M
Current Assets	GBX 1.8M
Current Liabilities	GBX 1.2M
Debt	GBX 0
Equity	GBX 686,862
Interest Coverage	-291.4
Liabilities	GBX 1.2M
Long Term Assets	GBX 64,528
Long Term Liabilities	GBX 0
Net Cash	GBX 1.4M
Net Cash By Market Cap	GBX 4.82
Net Cash Growth	470.81%
Net Debt Equity	GBX -1.97
Tangible Book Value	GBX 686,862
Tangible Book Value Per Share	GBX 0
WACC	20.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.52
Net Working Capital	GBX -729,915
Quick ratio	1.46
Working Capital	GBX 622,334

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-88.31%
1Y total return	112.77%
200-day SMA	6.34
3Y total return	79.64%
50-day SMA	4.22
50-day SMA vs 200-day SMA	50under200
5Y total return	-48.39%
All Time High	193.7
All Time High Change	-97.68%
All Time High Date	2018-01-03
All Time Low	0.82
All Time Low Change	447.45%
All Time Low Date	2024-03-01
ATR	0.66
Beta	3.02
Beta1y	1.05
Beta2y	0.8
Ch YTD	-27.42
High	4.5
High52	19.4
High52 Date	2025-09-15
High52ch	-76.8%
Low	3.9
Low52	1.39
Low52 Date	2025-08-13
Low52ch	224.68%
Ma50ch	6.69%
Price vs 200-day SMA	-29.02%
RSI	55.2
RSI Monthly	49.62
RSI Weekly	45.23
Sharpe ratio	1.11x
Sortino ratio	2.51
Total Return	-17.81%
Tr YTD	-27.42
Tr15y	-94%
Tr1m	9.76%
Tr3m	-0.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -2.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	604,461,892%
Shares Insiders	0.6%
Shares Institutions	87.02%
Shares Out	623,911,379
Shares Qo Q	4.49%
Shares Yo Y	17.81%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -2.5M
Average Volume	1,706,876.1x
Bv Per Share	0
CAPEX	GBX -1,652
Ch10y	-88.31
Ch15y	-94
Ch1m	9.76
Ch1y	112.8
Ch20y	-92.86
Ch3m	-0.66
Ch3y	79.64
Ch5y	-48.39
Ch6m	-32.43
Change	12.5%
Change From Open	15.38
Close	4
Days Gap	-2.5
Depreciation Amortization	35,296
Dollar Volume	2,973,172.5
Earnings Date	2026-08-05
EBIT	GBX -2.5M
EBITDA	GBX -2.5M
EPS	GBX -0
F Score	1
FCF	GBX -2.4M
FCF EV Yield	-8.88x
FCF Per Share	GBX -0
Financing CF	3,431,579
Fiscal Year End	December
Founded	1,999
Income Tax	GBX -364,499
Investing CF	12,624
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Ma150	5.41
Ma150ch	-16.74%
Ma20	3.96
Ma20ch	13.69%
Net CF	1,115,347
Next Earnings Date	2026-08-05
Open	3.9
Position In Range	100
Ppne	64,528
Price Date	2026-07-24
Ptbv Ratio	40.88
Relative Volume	0.39x
Share Based Comp	107,896
Tr20y	-92.86%
Tr6m	-32.43%
Volume	660,705

AIM/IMM (AIM/IMM)

Coverage state: Market snapshot only — no published research

Generate the first AIM/IMM analysis

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/IMM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/IMM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AIM/IMM

Frequently asked questions